Agency Continues to Support Development of Overdose Reversal Drugs including Naloxone and Nalmefene SILVER SPRING, Md., Aug. 7, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Zurnai, the first nalmefene hydrochloride auto-injector for […]
